This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,066,804 units of the prescription drug Ondansetron Hydrochloride 4 mg Tablets. The delivery order contract has a firm fixed price of $8,088.22 and a completion date of October 10, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its corporate office division, will provide these critical medications to support military treatment facilities and other federal healthcare providers nationwide. This award is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of pharmaceutical products and medical supplies to the U.S. Department of Defense.
Generated 1/8/25, 9:03 AM